Suppr超能文献

增强超声特征可预测经皮微波消融治疗肝内胆管细胞癌的预后。

Contrast-enhanced ultrasound features predict the prognosis of percutaneous microwave ablation of intrahepatic cholangiocarcinoma.

机构信息

Department of Interventional Ultrasound, The Fifth Medical Center of PLA General Hospital, Beijing, China.

Department of Ultrasound, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

出版信息

Br J Radiol. 2022 May 1;95(1133):20211379. doi: 10.1259/bjr.20211379. Epub 2022 Feb 9.

Abstract

OBJECTIVE

To evaluate the prognostic effect of pre-operative contrast-enhanced ultrasound (CEUS) features on intrahepatic cholangiocarcinoma (ICC) after percutaneous microwave ablation (MWA).

METHODS

A total of ICC 29 patients (average age 56.34 ± 9.78 years old, 33~75 years old) underwent MWA from March 2012 to December 2020, with a total of 58 lesions (0.5-8.1 cm, mean diameter, 2.68 ± 1.59 cm), and their pre-operative CEUS images and clinical data were collected and reviewed. Survival rate, local progression rate, intra- and extrahepatic metastasis rate were evaluated. Uni- and multivariate analysis were used to analyze the prognostic factors affecting the survival of ICC patients with pre-operative CEUS features.

RESULTS

The median follow-up time after MWA was 18.43 months (4.17-93.13 months). 1-, 2-, and 3-year OS rates were 64.4%, 48.1% and 48.1%; 6-, 12-, 18-, 24-, 36-, 48-, and 60-month local progress and extrahepatic metastasis rates were 0.0%, 4.0%, 17.7%, 17.7%, 17.7%, 17.7%, 17.7% and 3.4%, 21.5%, 32.7%, 45.6%, 55.2%, 55.2% and 77.6%, respectively. Uni- and multivariate analysis showed that post-operative extrahepatic metastasis was an important factor for long-term survival of ICC patients after MWA ( = 0.006, 0.01), and Rim-enhancement feature of pre-operative CEUS was identified as an independent predictor of post-operative extrahepatic metastasis and long-term survival ( = 0.02, 0.02).

CONCLUSION

Rim-enhancement feature of pre-operative CEUS is a predictor high post-operative extrahepatic metastasis and poor prognosis through distant microvascular metastasis after MWA of ICC patients.

ADVANCES IN KNOWLEDGE

This study determined the important CEUS features of ICC and analyzed their impact on the prognosis of ICC patients after MWA, providing scientific guidance for better clinical treatment in the future.

摘要

目的

评估术前对比增强超声(CEUS)特征对经皮微波消融(MWA)后肝内胆管癌(ICC)的预后影响。

方法

2012 年 3 月至 2020 年 12 月,共 29 例 ICC 患者(平均年龄 56.34±9.78 岁,3375 岁)接受 MWA 治疗,共 58 个病灶(0.58.1cm,平均直径 2.68±1.59cm),收集并回顾了患者的术前 CEUS 图像和临床资料。评估了生存率、局部进展率、肝内和肝外转移率。采用单因素和多因素分析,分析了术前 CEUS 特征对 ICC 患者生存的影响预后因素。

结果

MWA 后中位随访时间为 18.43 个月(4.17~93.13 个月)。1、2、3 年 OS 率分别为 64.4%、48.1%和 48.1%;6、12、18、24、36、48 和 60 个月的局部进展和肝外转移率分别为 0.0%、4.0%、17.7%、17.7%、17.7%、17.7%、17.7%和 3.4%、21.5%、32.7%、45.6%、55.2%、55.2%和 77.6%。单因素和多因素分析表明,MWA 后肝外转移是 ICC 患者长期生存的重要因素( = 0.006,0.01),术前 CEUS 的 Rim 增强特征被确定为术后肝外转移和长期生存的独立预测因子( = 0.02,0.02)。

结论

术前 CEUS 的 Rim 增强特征是 ICC 患者 MWA 后远处微血管转移导致肝外转移和预后不良的预测因子。

知识进展

本研究确定了 ICC 的重要 CEUS 特征,并分析了其对 ICC 患者 MWA 后预后的影响,为今后更好的临床治疗提供了科学指导。

相似文献

1
2
Assessment of the Outcomes of Intrahepatic Cholangiocarcinoma After Ultrasound-Guided Percutaneous Microwave Ablation Based on Albumin-Bilirubin Grade.
Cardiovasc Intervent Radiol. 2021 Feb;44(2):261-270. doi: 10.1007/s00270-020-02637-9. Epub 2020 Oct 14.
3
Enhancement Patterns of Intrahepatic Cholangiocarcinoma on Contrast-Enhanced Ultrasound: Correlation with Clinicopathologic Findings and Prognosis.
Ultrasound Med Biol. 2019 Jan;45(1):26-34. doi: 10.1016/j.ultrasmedbio.2018.08.014. Epub 2018 Oct 3.
6
Clinical and survival outcomes of percutaneous microwave ablation for intrahepatic cholangiocarcinoma.
Int J Hyperthermia. 2018 May;34(3):292-297. doi: 10.1080/02656736.2017.1327678. Epub 2017 May 19.
7
8
Percutaneous ultrasound-guided thermal ablation for intrahepatic cholangiocarcinoma.
Br J Radiol. 2012 Aug;85(1016):1078-84. doi: 10.1259/bjr/24563774. Epub 2012 Feb 28.
10
Radiofrequency ablation for the treatment of primary intrahepatic cholangiocarcinoma.
AJR Am J Roentgenol. 2011 Feb;196(2):W205-9. doi: 10.2214/AJR.10.4937.

引用本文的文献

1
Ultrasound-guided percutaneous thermal and non-thermal ablation of intrahepatic cholangiocarcinoma.
World J Gastroenterol. 2025 Sep 14;31(34):108623. doi: 10.3748/wjg.v31.i34.108623.
2
Efficacy of microwave ablation for intrahepatic cholangiocarcinoma: a systematic review and meta-analysis.
Quant Imaging Med Surg. 2025 Jan 2;15(1):760-769. doi: 10.21037/qims-24-607. Epub 2024 Dec 30.
4
Locoregional Therapy for Intrahepatic Cholangiocarcinoma.
Cancers (Basel). 2023 Apr 20;15(8):2384. doi: 10.3390/cancers15082384.
6
Complications after Thermal Ablation of Hepatocellular Carcinoma and Liver Metastases: Imaging Findings.
Diagnostics (Basel). 2022 May 5;12(5):1151. doi: 10.3390/diagnostics12051151.

本文引用的文献

1
Patient-Derived Organoids of Cholangiocarcinoma.
Int J Mol Sci. 2021 Aug 12;22(16):8675. doi: 10.3390/ijms22168675.
4
Current Advances in Basic and Translational Research of Cholangiocarcinoma.
Cancers (Basel). 2021 Jul 1;13(13):3307. doi: 10.3390/cancers13133307.
7
The Asian Federation of Societies for Ultrasound in Medicine and Biology (AFSUMB) Guidelines for Contrast-Enhanced Endoscopic Ultrasound.
Ultrasound Med Biol. 2021 Jun;47(6):1433-1447. doi: 10.1016/j.ultrasmedbio.2021.01.030. Epub 2021 Feb 27.
8
Surgical Treatment of Intrahepatic Cholangiocarcinoma: Current and Emerging Principles.
J Clin Med. 2020 Dec 30;10(1):104. doi: 10.3390/jcm10010104.
9
Neoadjuvant treatment strategies for intrahepatic cholangiocarcinoma.
World J Hepatol. 2020 Oct 27;12(10):693-708. doi: 10.4254/wjh.v12.i10.693.
10
Assessment of the Outcomes of Intrahepatic Cholangiocarcinoma After Ultrasound-Guided Percutaneous Microwave Ablation Based on Albumin-Bilirubin Grade.
Cardiovasc Intervent Radiol. 2021 Feb;44(2):261-270. doi: 10.1007/s00270-020-02637-9. Epub 2020 Oct 14.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验